Latest From Biotech Now

Recent Developments in Patentability: Prometheus and Myriad

supreme-court

By Joe Allen, President, Allen and Associates Recent Developments in Patentability: Prometheus and Myriad at the 2012 BIO International Convention was a very lively panel discussion on two cases that have set the life science industry on edge. The discussion presented an appropriate diversity of views as experts struggle with how broadly these cases should be interpreted. Briefly, the unanimous decision by the Supreme Court overtuning a decision upholding the Prometheus patents by the Court Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Official Blogger Roundup

Official Blogger

Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Denmark leads the world in its pro-research attitude #bio2012, Biotech Blog Bioentrepreneurship Bootcamp signing at #bio2012, Biotech Blog Welcome to BIO 2012!, Campaign for Modern Medicine Greetings from BIO 2012!, The Cross-Border Biotech Blog BIORadio Lands in Boston, Genomics Blog Kicking off #BIO2012, LillyPad Research Partnerships Catalyze Economic Growth, LillyPad The BIO Official Bloggers Take Boston, Patent Baristas BIO Day 1: China, IP and Savings Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

From Bench to Bedside in a Bioeconomy

lab_tech02-btn

By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program when the closing panel reinforces the opening speaker. Boston University President Robert Brown kicked off the afternoon at the Translational Research Forum at the 2012 BIO International Convention by showing how the old linear model of product development crafted after World War II no longer applies. The closing industry panel aptly remarked that a struggling economy has brought the public and private Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Dr. Lewis Sullivan Leads Panel on Diversity in Education and the Biotech Workplace

Luis Sullivan

This year the Diversity Summit at the 2012 BIO International Convention focused on the importance of recruiting and fostering a diverse workforce in the biotechnology field. Past Diversity Summits have focused on diversity in research and clinical trials, but experts have found that it can be challenging to develop new treatments and cures without a diverse workforce pursuing these discoveries. For panelists as well as those in the audience, the need to bring minorities into Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Five Keys to Making Biotech Flourish in China

baier-china

As China positions itself as a major global player in the international biotechnology arena, it has included biotechnology as one of the seven strategic priorities for scientific and technological development in its 12th Five-year Plan. During the keynote lunch of the China Day special program at the 2012 BIO International Convention, David W. Beier, senior vice president at Amgen and former chief domestic policy advisor to Vice President Al Gore, outlined the 5 keys to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,